HL7 Specifications
Published
HL7 CDA® R2 Implementation Guide: Quality Reporting Document Architecture (QRDA III), Release 1, STU Release 2.1
HL7 CDA® R2 Implementation Guide: Quality Reporting Document Architecture (QRDA III), Category III, Release 1
HL7 CDA® R2 Implementation Guide: Quality Reporting Document Architecture I (QRDA I) Release 1, STU Release 5.3
HL7 CDA® R2 Implementation Guide: Healthcare Associated Infection (HAI) Reports, Release 3
HL7 CDA® R2 Implementation Guide: Consolidated CDA Templates for Clinical Notes, Release 2.1
The C-CDA R2.1 Implementation Guide (IG) provides an overview of the Clinical Document Architecture (CDA) base standard and provides information on how to understand and use CDA templates CDA templates for representing common clinical document types are defined in the IG at the document, section, entry level, and other supporting templates.
HL7 FHIR® US Core Implementation Guide, v3.1.1 – STU3
The US Core Implementation Guide is based on FHIR Version R4 and defines the minimum set of constraints on the FHIR resources to create the US Core Profiles. It also defines the minimum set of FHIR RESTful interactions for each of the US Core Profiles to access patient data.
HL7 FHIR® Implementation Guide: Coverage Requirements Discovery, Release 2.0.1
This specification provides a mechanism for healthcare providers to discover guidelines, pre-authorization requirements and other expectations from payor organizations related to a proposed medication, procedure or other service associated with a patient’s insurance coverage. It supports both patient-specific and patient-independent information retrieval.
HL7 FHIR® IG: SMART Application Launch Framework, v2.0.0
HL7 CDA® R2 IG: C-CDA Templates for Clinical Notes STU Companion Guide Release 3
The Office of the National Coordinator (ONC) releases periodic proposed rules, and final rules, which reference the use of Consolidated CDA (C-CDA). The Companion Guide to Consolidated Clinical Document Architecture (C-CDA) provides supplemental guidance.